News

Why Is Repare Therapeutics Stock Trading Lower On Friday?

On Thursday, Repare Therapeutics Inc (NASDAQ:RPTX) revealed data from its MYTHIC Phase 1 gynecologic expansion trial evaluating the combination of lunresertib and camonsertib (Lunre+Camo) for endometrial cancer and platinum-resistant ovarian cancer (PROC) harboring lunre-sensitizing biomarkers. As of the data cut-off date of November 14, 51 evaluable patients were enrolled in the gynecologic cancer expansion cohort of the MYTHIC trial. Across all tumor types treated at the optimized RP2D (n=67),

Costco's Unique Retail Model And Solid Growth Stand Out In Challenging Market: Analysts

JP Morgan analyst Christopher Horvers reiterated the Overweight rating on Costco Wholesale Corporation (NASDAQ:COST) with a price forecast of $1,090. The analyst suggests that the ongoing global momentum in the business, share gains across various sectors and geographies (including e-commerce growth), and the company’s leverage to a cyclical upswing in big-ticket items (about 20% of the comp) contribute to its strong performance. Additionally, the emerging benefits from advertising revenue make

Exclusive-Heavy rains to hit Malaysian palm oil output again in December, says MPOB

Malaysia's palm oil production is set to fall for the fourth consecutive month in December as heavy rainfall hit harvesting in the world's second-largest producer of the tropical oil, the industry regulator told Reuters on Friday. Lower output in Malaysia would curb inventories in the country and further boost benchmark futures, which are already near their highest levels in about 2-1/2 years. "We estimate a potential reduction of around 5% to 8% in crude palm oil (CPO) production under normal circumstances," Ahmad Parveez Ghulam Kadir, director-general at the Malaysian Palm Oil Board (MPOB) said.